Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
See You There Tomorrow at Pharma’s Bet on Boston Innovation
|
Luke Timmerman |
11/03/09 |
Boston
|
|
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/28/09 |
Boston
|
|
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data
|
Luke Timmerman |
05/15/09 |
Boston
|
|
A123Systems Gives Chrysler a Charge, Segway Scoots into GM Deal, Basho Banks $2M, & More Boston-Area Deals News
|
Rebecca Zacks |
04/10/09 |
Boston
|
|
Dendreon Saga Nears Climax, Gregoire Biotech Fund in Jeopardy, UW’s Biofuel Futurist, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/09/09 |
Seattle
|
|
Swype Scores $1.3M, Onehub Raises $600K, Genzyme Comes to Town, & More Seattle-Area Deals News
|
Gregory T. Huang |
04/07/09 |
Seattle
|
|
Hey Life Sciences Fans, Remember The Deals Back in 2008…
|
Ryan McBride |
01/05/09 |
Boston
|
|
Blood News: A Quick Rundown of Headlines From the American Society of Hematology
|
Luke Timmerman |
12/09/08 |
National
|
|
Millennium’s Velcade, As Time Wears On, Shows Durable Ability to Prolong Lives
|
Luke Timmerman |
12/08/08 |
Boston
|
|
Millennium CEO Dunsire Juggles Growing Pipeline, Works to Maintain Nimble Culture—as New Owner Takeda Makes the Company its Center for Cancer Drug Development
|
Luke Timmerman |
09/10/08 |
Boston
|
|
Takeda Takes Hold of Millennium for $8.8 Billion
|
Rebecca Zacks |
04/10/08 |
Boston
|
|
Millennium Presents Positive Data for Velcade
|
Malorye Allison |
12/11/07 |
Boston
|
|
Market Likes Millennium’s Velcade News; Analysts Not So Sure
|
Rebecca Zacks |
09/18/07 |
Boston
|
|
Just Launched into the Boston VC Orbit: Third Rock Ventures
|
Rebecca Zacks |
09/14/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
